Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Prostate Neoplasm”

236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 236 results

Testing effectiveness (Phase 2)Study completedNCT05407311
What this trial is testing

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 53
Large-scale testing (Phase 3)Study completedNCT04534075
What this trial is testing

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of RectumMalignant Neoplasm of Anus+7 more
Sahlgrenska University Hospital 354
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableUnknownNCT04124107
What this trial is testing

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection

Who this might be right for
Prostate Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableStudy completedNCT05162846
What this trial is testing

Michigan Genetic Hereditary Testing (MiGHT)

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+4 more
University of Michigan Rogel Cancer Center 793
Not applicableLooking for participantsNCT06315595
What this trial is testing

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

Who this might be right for
Prostate Neoplasm
Mayo Clinic 1,000
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableStudy completedNCT01973673
What this trial is testing

Healthy Bones Study

Who this might be right for
Locally Advanced Malignant Neoplasm
University Health Network, Toronto 200
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Not applicableUnknownNCT01764646
What this trial is testing

Hypofractionated Radiation Therapy in Prostate Cancer

Who this might be right for
Malignant Neoplasm of ProstateLocal Disease
Thomas Zilli 170
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Not applicableActive Not RecruitingNCT05830838
What this trial is testing

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

Who this might be right for
Malignant Prostate Neoplasm
Mayo Clinic 50
Not applicableStudy completedNCT03321149
What this trial is testing

Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy

Who this might be right for
Prostate CancerProstate NeoplasmCancer+1 more
University of Illinois at Urbana-Champaign 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Early research (Phase 1)Study completedNCT00441337
What this trial is testing

MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more
Bristol-Myers Squibb 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04045717
What this trial is testing

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

Who this might be right for
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Universitaire Ziekenhuizen KU Leuven 124
Large-scale testing (Phase 3)Study completedNCT02712320
What this trial is testing

Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg

Who this might be right for
Prostatic Neoplasms
Foresee Pharmaceuticals Co., Ltd. 30
Next Page